Financials

  • Market Capitalization 1.37 B
  • Employee 110
  • Founded 2024
  • CEO N/A
  • Website www.inhibrx.com
  • Headquarter Delaware, United States
  • FIGI BBG01MS5Q9G3
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-8.01
주가매출액비율

Related tickers

#이름가격24h %7d %1M %1Y %마켓 캡이전 7일
2214
XERS
Xeris Biopharma Holdings, Inc. - Common Stock
8.28 USD+1.47%-6.65%+20.17%+55.64%1.43 B USD
2240
NVAX
Novavax, Inc. - Common Stock
8.42 USD-5.50%-9.27%-8.68%+21.68%1.38 B USD
2302
ARDX
Ardelyx, Inc. - Common Stock
5.16 USD+0.39%-3.19%-10.10%+14.16%1.27 B USD
2310
CRVS
Corvus Pharmaceuticals, Inc. - Common Stock
14.97 USD+1.77%-3.61%+21.02%+258.99%1.26 B USD

뉴스